84% of NET patients
lack information
Their needs for information about treatment
options were not met at the time of diagnosis.
58% of NET patients are
diagnosed at an advanced stage
How Can I Help?
Latest News
The Cost of Neuroendocrine Tumor Patient Healthcare Showcased at ASCO Quality Care Symposium
INCA is proud to share that The Cost of Neuroendocrine Tumor Patient Healthcare: Comparison between Advanced Economies and Emerging and Developing Economies was selected for presentation at the 2021 ASCO Quality Care Symposium (September 24-25, 2021) which will be...
Advanced NET Treatments Now Accessible in India
Neuroendocrine tumor treatment Lutetium 177 Dota therapy is now available in more than 15 hospitals in India in all major cities like Delhi, Mumbai, Chandigarh, Lucknow, Pune, Kolkata, Chennai, Hyderabad and others. Advanced alpha therapy is also available at few...
CCF’s Luncheon With the Experts Featuring CNETS India Founder
Sugandha Dureja, MD, FEBNM, nuclear medicine expert and founder of CNETS India, was the featured guest for the Carcinoid Cancer Foundation’s Luncheon with the Experts Facebook Live program on August 12, 2021. Dr. Dureja is among the first Indian specialists with...